Immunological properties of beta-lactamases that hydrolyze cefuroxime and cefotaxime
Author(s) -
Kanji Hirai,
Kenichi Sato,
N Matsubara,
Ryoichi Katsumata,
Manabu Inoue,
S Mitsuhashi
Publication year - 1981
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.20.2.262
Subject(s) - cefotaxime , cefuroxime , proteus vulgaris , microbiology and biotechnology , proteus , pseudomonas , beta (programming language) , antiserum , cephalosporin , beta lactamase , chemistry , biology , bacteria , antibiotics , pseudomonas aeruginosa , biochemistry , antibody , immunology , escherichia coli , genetics , gene , computer science , programming language
Antiserum against purified beta-lactamase from Proteus vulgaris GN7919 cross-reacted with beta-lactamases produced by strains of Pseudomonas cepacia in a neutralization test. Anti-P. cepacia beta-lactamase serum, however, did not show any cross-reactions with P. vulgaris beta-lactamases. Each of these enzymes can hydrolyze cefuroxime and cefotaxime.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom